Pharmacokinetic Study of Omecamtiv Mecarbil in Heart Failure Patients

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

July 31, 2010

Primary Completion Date

May 31, 2011

Study Completion Date

May 31, 2011

Conditions
Heart Failure
Interventions
DRUG

Omecamtiv mecarbil

Oral dosing twice each day or three times each day, depending on the cohort assignment, of Omecamtiv mecarbil for 8 days. Omecamtiv mecarbil comes in 2 formulations: modified release and immediate release, and the formulation given will depend on the cohort assignment.

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Cytokinetics

INDUSTRY

NCT01077167 - Pharmacokinetic Study of Omecamtiv Mecarbil in Heart Failure Patients | Biotech Hunter | Biotech Hunter